David NuttNeuropsychopharmacology Unit, Imperial College London, London, UK F1000 Section Head (since 16 November 2005)
David Nutt is currently the Edmond J Safra Professor of Neuropsychopharmacology and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences.
• Fellow of the Royal College of Physicians, Royal College of Psychiatrists and the Academy of Medical Sciences
• Visiting professor in Australia, New Zealand and the Netherlands
• President of British Association of Psychopharmacology and the European College of Neuropsychopharmacology
The goal of the department is to pioneer research into neuro-psychiatric disorders merging pharmacological approaches with state-of-the-art imaging techniques. The particular emphasis is on brain disorders such as addiction dementia schizophrenia and affective disorders.
Recent discoveries include clarifying the role of dopamine in both schizophrenia and opioid addiction - the discovery of an antagonist of the memory-blocking properties of alcohol - showing opioid receptors are involved in alcohol as well as heroin dependence and developing new potential PET tracers for studying noradrenaline and imidazoline receptors in conditions such as depression and dementias.
There are close links with the MRC Clinical Sciences Centre where DJN and ALH have conducted PET imaging studies for many years and also with the GSK Clinical Imaging Centre, which is collocated in the Burlington-Danes building alongside the dept. DJN leads an international consortium underthe EuroBioFund program that is seeking new PET tracers to allow measurement of endogenous neurotransmitter release in the human brain.
Professor David Nutt talks about his work at Imperial College studying the molecular underpinnings of addiction. [Video uploaded 02 June 2011]
David Nutt has been added to your "Faculty I'm Following" page in MyF1000
Follow/Unfollow any Faculty via their recommendations, biography pages, or MyF1000